Legend Biotech

Our #ASCO26 Investor Relations event is happening on Sunday, May 31. Join us as we discuss CAR-T therapies and our progress in multiple myeloma. Register here: bit.ly/4wyn5xk #CellTherapy

#LegendNews: Early LB2102 data in solid tumors will be presented at #ASCO26. Additional data presented at @ASCO reinforce established efficacy and safety profile in #MultipleMyeloma. Come find us at ASCO Booth #21955 to learn more and read more at: bit.ly/4f16QCG

At @ASCO, we'll present new data across our cell therapy portfolio, including investigational LB2102 findings in solid tumors and our CAR-T program in multiple myeloma. We remain focused on advancing cell therapy innovation and oncology research. #ASCO26 #CellTherapy

Advancing #PatientCare is a team effort. This week at #ONS2026, the Legend team is connecting with #Oncology nurses and care teams to share perspectives, learn from each other, and support the delivery of advanced therapies. Stop by and visit our booth #1103 to learn more.

#LegendNews: Today, we shared our Q1 2026 financial results. Read more: investors.legendbiotech.com/news-releases/… $LEGN #Earnings

#LegendNews: Legend has engaged leading scientific advisors to help guide the advancement of our pipeline and next-generation cell therapy innovation. Their expertise across oncology, immunology & translational science will help shape our R&D strategy. 🔗investors.legendbiotech.com/news-releases/…

#LegendNews: Legend will announce its Q1 2026 #FinancialResults on Tuesday, May 12, at 8 a.m. ET. Join our webcast for an update on our progress: investors.legendbiotech.com/events-and-pre… $LEGN

Heading to #iwCART2026? Legend is back as a Silver Sponsor in Tampa, April 24–26! 📍 Session 17: CARs for #MultipleMyeloma 🗓️ April 25 | 1:30 PM 🎙️ Dr. Rakesh Popat will share the latest updates on the CARTITUDE-4 study. View the program: iwcar-t.org #CellTherapy

#LegendNews: Research highlighting our investigational solid tumor CAR-T and continued evidence generation in multiple myeloma from our #CellTherapy portfolio will be presented at @ASCO. Attending #ASCO26? Visit booth #29155 to say hello! #ASCO26 #Biotech #CancerResearch

📅 Apr 16 at 3 PM CAR‑T insights you won’t want to miss! Join @BloodCancerUtd + Dr. Vu Nguyen, for an educational webcast on CAR‑T treatment, side effects & what’s next. ✅ Sponsored by Legend and @JNJNews 🔗bloodcancerunited.org/resources/educ… #CARTCellTherapy #BloodCancer #Oncology

We’re proud to return as a Silver Sponsor of #iwMyeloma 2026 in Miami! Legend is joining global leaders to translate evolving science into clinical practice and shape what’s next for patients. See you there! View the program: iwmyeloma.com #MultipleMyeloma #Hematology

April 5 marks two years since FDA approval of our CAR-T #CellTherapy for 2L treatment of adults with r/r #MultipleMyeloma. More than 10,000 patients treated worldwide —and we remain focused on expanding what’s possible with cell therapy. #BloodCancer #PatientsFirst

April is National #MinorityHealthMonth. At Legend Biotech, our commitment goes beyond science—we work to advance cell therapies responsibly, support inclusive clinical research, and help reduce barriers to care so innovation can reach more patients. #HealthEquity #BloodCancer

This #NationalDoctorsDay, we recognize oncologists & hematologists whose dedication and collaboration help move cancer care forward—especially those in the community who advocate for access and guide patients every step of the way. 🔗Read more @GoHealio: healio.com/advertorial/20…

We're officially on-site as a Silver Sponsor of the @Myeloma_Society Immune Effector Cell Therapies in Multiple Myeloma Workshop in Boston. If you’re attending, we’d love to connect and discuss the future of #CellTherapy. More: myelomasociety.org/events/7th-imm…

Over the weekend, our #LEGENDary team had an amazing day at the @IMFMyeloma 5K in Los Angeles! Thank you to everyone who joined in support of the #MultipleMyeloma community and helped amplify awareness during #MyelomaActionMonth. #WeAreLegend #BloodCancer #PatientsFirst

At Legend, our "Patient First" mission inspires us to empower the #BloodCancer community. This #MyelomaAwarenessMonth, we’re proud to highlight the work of @BloodCancerUtd. No one should face this journey alone. 💡bloodcancerunited.org/resources/pati… #MultipleMyeloma

Alan Bash, President of our CAR-T #CellTherapy, recently joined the Business of Biotech podcast with host @BenMComer to share insights on progress in #MultipleMyeloma, the role of innovation and global collaboration. Full episode: bioprocessonline.com/doc/commercial… #Biotech

What would you say to someone who’s just been diagnosed? What can you share to remind them we are #MoreThanMyeloma? Spread hope. Share with us below. Thank you to @LegendBiotech @LegendUSMA for helping us spread myeloma awareness.

@IMFmyeloma @LegendUSMA You are #MoreThanMyeloma. ❤️